Showing 8 of 8 recruiting trials for “adrenocortical-carcinoma”
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
👨⚕️ Peng Wu, Ph.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China📍 2 sites📅 Started Feb 2025View details ↗
RecruitingNCT06861530 ↗
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →